Skip Navigation LinksHome > March 2014 - Volume 114 - Issue 3 > New Antiseizure Medication Approved
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000444487.71962.61
Drug Watch

New Antiseizure Medication Approved

Aschenbrenner, Diane S. MS, RN

Collapse Box

Abstract

* Eslicarbazepine acetate (Aptiom) is a new voltage-gated sodium channel inhibitor approved for use in the treatment of partial-onset seizures. It's used as part of combination therapy.

* The most common adverse effects are similar to those of many other antiepileptic drugs and include central nervous system and gastrointestinal effects. The drug also carries risks of serious skin reactions, drug reactions with eosinophilia and systemic symptoms, anaphylaxis, significant hyponatremia, and liver injury.

© 2014 Lippincott Williams & Wilkins. All rights reserved.

Login